Clinical Trial Update: Research on the Application of 68Ga-PSMA-CYC PET Imaging in the Diagnosis, Staging, and Restaging of Prostate Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 clinical trial evaluating 68Ga-PSMA-CYC PET imaging for diagnosis, staging, and restaging of prostate cancer, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• 68Ga-PSMA-CYC (68Ga-PSMA-CYC)

Snippet

Sponsor: First Affiliated Hospital of Fujian Medical University | Conditions: Prostate CA | Phase 1, Phase 2 | Status: RECRUITING